Clinical Trial Update: Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update on efficacy and safety of IBI308 combined with Paclitaxel/Albumin Paclitaxel in extensive-stage small cell lung cancer after failure of eto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• IBI308 (IBI308)
• Paclitaxel/Albumin Paclitaxel (Paclitaxel)

Snippet

Sponsor: Junling Li | Conditions: Extensive-Stage Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN